ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,776,781 | -12.6% | 6,605,933 | -4.9% | 0.00% | – |
| Q2 2023 | $11,183,593 | -43.7% | 6,946,331 | +1.3% | 0.00% | -100.0% |
| Q1 2023 | $19,880,040 | -15.9% | 6,855,186 | -4.9% | 0.00% | 0.0% |
| Q4 2022 | $23,652,237 | -5.3% | 7,211,048 | +9.2% | 0.00% | 0.0% |
| Q3 2022 | $24,973,000 | -56.1% | 6,606,509 | -9.5% | 0.00% | -50.0% |
| Q2 2022 | $56,852,000 | -11.5% | 7,298,073 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $64,217,000 | -42.4% | 6,912,574 | -2.3% | 0.00% | -33.3% |
| Q4 2021 | $111,510,000 | -8.4% | 7,075,521 | +4.0% | 0.00% | 0.0% |
| Q3 2021 | $121,730,000 | +16.8% | 6,800,583 | +1.4% | 0.00% | 0.0% |
| Q2 2021 | $104,250,000 | +14.3% | 6,704,141 | +5.5% | 0.00% | +50.0% |
| Q1 2021 | $91,226,000 | -17.6% | 6,352,807 | +12.7% | 0.00% | -33.3% |
| Q4 2020 | $110,680,000 | +78.0% | 5,638,274 | +17.5% | 0.00% | +50.0% |
| Q3 2020 | $62,197,000 | -8.1% | 4,799,238 | +3.4% | 0.00% | 0.0% |
| Q2 2020 | $67,643,000 | +108.0% | 4,642,630 | +21.5% | 0.00% | +100.0% |
| Q1 2020 | $32,527,000 | -46.4% | 3,822,326 | +3.8% | 0.00% | -50.0% |
| Q4 2019 | $60,637,000 | +19.9% | 3,681,701 | +2.8% | 0.00% | 0.0% |
| Q3 2019 | $50,571,000 | -16.5% | 3,581,453 | +18.9% | 0.00% | 0.0% |
| Q2 2019 | $60,563,000 | -47.1% | 3,011,596 | +4.6% | 0.00% | -50.0% |
| Q1 2019 | $114,453,000 | +17.0% | 2,879,314 | +2.2% | 0.00% | 0.0% |
| Q4 2018 | $97,843,000 | -4.9% | 2,816,441 | +13.2% | 0.00% | 0.0% |
| Q3 2018 | $102,861,000 | +17.5% | 2,487,567 | +4.5% | 0.00% | 0.0% |
| Q2 2018 | $87,515,000 | +41.9% | 2,381,354 | +50.5% | 0.00% | +33.3% |
| Q1 2018 | $61,693,000 | +263.6% | 1,581,840 | +68.7% | 0.00% | +200.0% |
| Q4 2017 | $16,967,000 | +11.7% | 937,492 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $15,195,000 | +28.3% | 918,150 | +8.5% | 0.00% | 0.0% |
| Q2 2017 | $11,842,000 | -30.7% | 845,877 | +1.7% | 0.00% | 0.0% |
| Q1 2017 | $17,095,000 | +60.5% | 831,925 | +10.9% | 0.00% | 0.0% |
| Q4 2016 | $10,653,000 | -29.0% | 750,291 | +7.0% | 0.00% | 0.0% |
| Q3 2016 | $14,995,000 | -2.0% | 701,040 | +3.1% | 0.00% | 0.0% |
| Q2 2016 | $15,300,000 | +42.3% | 679,690 | +20.3% | 0.00% | 0.0% |
| Q1 2016 | $10,750,000 | -30.2% | 564,956 | -3.1% | 0.00% | 0.0% |
| Q4 2015 | $15,401,000 | -94.9% | 583,135 | -92.7% | 0.00% | -90.9% |
| Q3 2015 | $302,852,000 | +1527.4% | 8,032,059 | +2177.2% | 0.01% | +1000.0% |
| Q2 2015 | $18,609,000 | +106.8% | 352,709 | +62.9% | 0.00% | 0.0% |
| Q1 2015 | $8,999,000 | +160.5% | 216,488 | +67.6% | 0.00% | – |
| Q4 2014 | $3,454,000 | – | 129,146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |